全文获取类型
收费全文 | 2173篇 |
免费 | 109篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 98篇 |
妇产科学 | 116篇 |
基础医学 | 181篇 |
口腔科学 | 46篇 |
临床医学 | 246篇 |
内科学 | 398篇 |
皮肤病学 | 50篇 |
神经病学 | 43篇 |
特种医学 | 312篇 |
外科学 | 231篇 |
综合类 | 136篇 |
预防医学 | 117篇 |
眼科学 | 13篇 |
药学 | 169篇 |
1篇 | |
中国医学 | 74篇 |
肿瘤学 | 52篇 |
出版年
2021年 | 17篇 |
2020年 | 15篇 |
2018年 | 17篇 |
2017年 | 21篇 |
2016年 | 19篇 |
2015年 | 43篇 |
2014年 | 52篇 |
2013年 | 56篇 |
2012年 | 80篇 |
2011年 | 75篇 |
2010年 | 64篇 |
2009年 | 55篇 |
2008年 | 72篇 |
2007年 | 67篇 |
2006年 | 77篇 |
2005年 | 48篇 |
2004年 | 53篇 |
2003年 | 42篇 |
2002年 | 46篇 |
2001年 | 39篇 |
2000年 | 46篇 |
1999年 | 48篇 |
1998年 | 57篇 |
1997年 | 65篇 |
1996年 | 54篇 |
1995年 | 47篇 |
1994年 | 61篇 |
1993年 | 41篇 |
1992年 | 29篇 |
1991年 | 24篇 |
1990年 | 35篇 |
1989年 | 44篇 |
1988年 | 35篇 |
1987年 | 43篇 |
1986年 | 36篇 |
1985年 | 26篇 |
1984年 | 24篇 |
1983年 | 21篇 |
1982年 | 15篇 |
1981年 | 29篇 |
1980年 | 21篇 |
1978年 | 13篇 |
1959年 | 35篇 |
1958年 | 58篇 |
1957年 | 87篇 |
1956年 | 45篇 |
1955年 | 75篇 |
1954年 | 68篇 |
1953年 | 17篇 |
1952年 | 14篇 |
排序方式: 共有2295条查询结果,搜索用时 19 毫秒
131.
132.
Thymic cysts in mediastinal Hodgkin disease 总被引:3,自引:0,他引:3
Three cases of proved thymic cysts associated with mediastinal Hodgkin disease are presented. Two illustrate regression of lymphoma with chemotherapy but persistence of thymic cysts. The third case demonstrates a thymic cyst in untreated Hodgkin disease. These cases suggest that such cysts are probably neither coincidental with nor a consequence of therapy but are probably related to initial thymic involvement by Hodgkin disease. 相似文献
133.
Daniel G. Schupp Hellmut Merkle Jutta M. Ellermann Yong Ke Michael Garwood Ph.D 《Magnetic resonance in medicine》1993,30(1):18-27
In vivo 1H MRS can be used to detect and quantify the lactate resonance at 1.3 ppm provided that overlapping lipid resonances are eliminated. A homonuclear spectral editing method was developed to acquire uncontaminated 1H spectra of lactate with adiabatic pulses. An advantage of the adiabatic pulse sequence is the ability to induce uniform flip angles and to maximize sensitivity in applications employing surface coil transmitters which produce highly inhomogeneous B1. Glycolytic activity in an intracerebral C6 glioma in rats was monitored by using adiabatic editing sequences to observe [3-13C]lactate produced from infused [1-13C]glucose. Acute hyperglycemia (serum glucose >22 mM, n = 10) had no significant effect (P = 0.08) on the total ([12C]+ [13C]) tumor lactate signal intensity. 相似文献
134.
135.
136.
137.
PETRERE JUDITH A.; HUMPHREY RONALD R.; ANDERSON JOHN A.; FITZGERALD JAMES E.; DE LA IGLESIA FELIX A. 《Toxicological sciences》1985,5(4):665-671
Studies on Reproduction in Rats with Meclofenamate Sodium, aNonsteroidal Anti-inflammatory Agent. PETRERE, J. A., HUMPHREY,R. R., ANDERSON, J. A., FITZGERALD, J. E., AND DE LA IGLESIA,F. A. (1985). Fundam. Appl. Toxicol. 5, 665671. Reproductionand teratology studies were performed in rats given meclofenamatesodium, a nonsteroidal anti-inflammatory agent. Dosages of 0,3, 6, and 9 mg/kg were administered orally as dietary admixturesin the Fertility and Perinatal-Postnatal studies. In the Teratologystudy, dosages of 10, 12, 15, and 20 mg/kg were administeredby intragastric intubation. In the Male-Fertility study no adverseeffects on fertility or litter and offspring parameters wereobserved in two generations. In the Female-Fertility and Perinatal-Postnatalstudies, maternal toxicity (death associated with intestinalulceration and adhesions) was particularly evident during lactation.Prolonged gestation periods, decreased weanling weights, andincreased weanling mortality were evident at dosages of 6 and9 mg/kg. Increased postimplantation loss occurred at 6 and 9mg/kg in the Term Sacrifice subgroup of the Female-Fertilitystudy. Fertility rates were unaffected and all other litterand offspring parameters of the F1 and F2 generations appearednormal. In the Teratology study no adverse effects on embryonicor fetal development were evident at maternally toxic dosagesup to 20 mg/kg. © 1985 Society of Texicology. 相似文献
138.
139.
140.
Koster A Huebler S Merkle F Hentschel T Gründel M Krabatsch T Tambeur L Praus M Habazettl H Kuebler WM Kuppe H 《Anesthesia and analgesia》2004,98(2):285-90, table of contents
Cardiac surgery involving cardiopulmonary bypass (CPB) leads to activation of the hemostatic/inflammatory system. We compared the influence of a half-dose aprotinin regimen on postoperative blood loss and the activation of the hemostatic/inflammatory system during CPB, when used during a heparin-level-based heparin management for cardiac surgery. Two-hundred patients (n = 100 in each group) were enrolled in this randomized prospective study. In Group I only heparin was given according to the results of the Hepcon HMS Plus. In Group II aprotinin was added with a bolus of 1 x 10(6) kallikrein inhibiting units (KIU) for the patient immediately before initiation of CPB, 1 x 10(6) KIU in the priming solution of the CPB, and a continuous infusion of 250,000 KIU/h during CPB. Postoperative blood loss was determined after 12 h. Heparin and antithrombin activity were evaluated by an anti-Xa assay and measurement of antithrombin III activity. Hemostatic activation was evaluated by adenosine diphosphate-stimulated platelet aggregometry and by measurements of the generation/release of beta-thromboglobulin (beta-TG), soluble P-selectin (sPS), thrombin (TAT), prothrombin 1 and 2 fragments (PTF1+2), factor XIIa (FXIIa), plasmin (PAP), and D-dimers. Inflammatory response was evaluated by measuring complement factors 5b-9 (C5b-9), interleukin (IL)-6, and neutrophil elastase (NE). There were no differences in the pre-CPB values or duration of CPB between the two groups. There were no differences in the post-CPB values for platelet count, platelet aggregation, beta-TG, sPS, TAT, PTF1+2, C5b-9, NE, or IL-6. The additional use of aprotinin resulted in a significant decrease of PAP, D-dimers, and 12 h postoperative blood loss, whereas generation of the contact factor XIIa was increased. The administration of aprotinin significantly reduced postoperative blood loss after cardiac surgery and CPB. This most likely has to be attributed to the antifibrinolytic effects of aprotinin. No effects on thrombin generation, platelet activation, inflammatory response, or clinical outcome were noted. IMPLICATIONS: The use of half-dose aprotinin and heparin-level-based anticoagulation management during cardiopulmonary bypass leads to a significant reduction of postoperative blood loss after cardiac surgery. This effect can most likely be attributed to the antifibrinolytic effects of aprotinin, as we did not observe effects on other variables of activation of the hemostatic/inflammatory system. 相似文献